WisdomTree BioRevolution Fund
$24.04-$0.63 (-2.56%)
WisdomTree BioRevolution Fund’s quoted price sits in the upper half of its reported 52-week range, 3.96% below the high.
NASDAQ · IBGK · USD
Stock price, dividends
Quote as of Oct 30, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
iShares iBonds Dec 2054 Term Treasury ETF’s quoted price sits in the lower half of its reported 52-week range, 9.85% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
iShares iBonds Dec 2054 Term Treasury ETF’s forward annual dividend is $1.08 per share, paid monthly. The forward yield is 4.91% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
The iShares iBonds Dec 2054 Term Treasury ETF is designed to emulate the financial returns of an index comprising U.S. government debt instruments scheduled to mature in 2054. This fund operates under the protection of U.S. Patent Nos. 8,438,100 and 8,655,770.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Nov 1, 2026, 10:23 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$24.04-$0.63 (-2.56%)
WisdomTree BioRevolution Fund’s quoted price sits in the upper half of its reported 52-week range, 3.96% below the high.
$28.32+$0.00 (+0.01%)
Federated Hermes MDT Market Neutral ETF’s quoted price sits in the upper half of its reported 52-week range, 2.58% below the high.
$47.63-$0.72 (-1.49%)
ProShares - Nasdaq-100 Dynamic Buffer ETF’s quoted price sits in the upper half of its reported 52-week range, 3.98% below the high.
$22.85+$0.02 (+0.1%)
ProShares - Decline of the Retail Store ETF’s quoted price sits in the lower half of its reported 52-week range, 12.2% below the high.
$33.09+$0.39 (+1.21%)
Direxion Daily MSCI Emerging Markets ex China Bull 2X Shares’s quoted price sits in the upper half of its reported 52-week range, 0.92% below the high.
$14.37+$0.52 (+3.77%)
Direxion Daily CSCO Bear 1X ETF’s quoted price sits in the lower half of its reported 52-week range, 39.31% below the high.
$10.47+$0.00 (+0.04%)
ProShares - UltraShort Nasdaq Biotechnology’s quoted price sits in the lower half of its reported 52-week range, 54.44% below the high.
$18.37+$0.50 (+2.83%)
STKd 100% SMCI & 100% NVDA ETF’s quoted price sits in the lower half of its reported 52-week range, 55.2% below the high.